Cargando…

LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes

Recent biochemical observations have helped redefine antigenic components within the voltage-gated potassium channel (VGKC) complex. The related autoantibodies may be now divided into likely pathogenic entities, which target the extracellular domains of leucine-rich glioma-inactivated 1 (LGI1) and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Binks, Sophie N M, Klein, Christopher J, Waters, Patrick, Pittock, Sean J, Irani, Sarosh R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Neuro-Inflammation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909759/ https://www.ncbi.nlm.nih.gov/pubmed/29055902 http://dx.doi.org/10.1136/jnnp-2017-315720

Ejemplares similares

LGI1 antibody encephalitis: acute treatment comparisons and outcome
por: Rodriguez, Andrew, et al.
Publicado: (2022)

Distinct HLA associations of LGI1 and CASPR2-antibody diseases
por: Binks, Sophie, et al.
Publicado: (2018)

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
por: Lang, Bethan, et al.
Publicado: (2017)

Randomized Placebo‐Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
por: Dubey, Divyanshu, et al.
Publicado: (2019)

Combining clinical and molecular heterogeneity within CASPR2-antibody mediated diseases: towards the underlying disease biology
por: Binks, Sophie, et al.
Publicado: (2020)

Clinical spectrum of high-titre GAD65 antibodies
por: Budhram, Adrian, et al.
Publicado: (2021)

Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies
por: McGinty, Ronan N, et al.
Publicado: (2021)

Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management
por: Abboud, Hesham, et al.
Publicado: (2021)

Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management
por: Abboud, Hesham, et al.
Publicado: (2021)

Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens
por: Hacohen, Yael, et al.
Publicado: (2013)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
por: Waters, Patrick, et al.
Publicado: (2016)

Phenotypic Spectrum of CASPR2 and LGI1 Antibodies Associated Neurological Disorders in Children
por: Jiang, Yan, et al.
Publicado: (2022)

Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
por: Mathey, Emily K, et al.
Publicado: (2015)

Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease
por: Rossi, Meghan, et al.
Publicado: (2015)

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
por: Ramanathan, Sudarshini, et al.
Publicado: (2018)

Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders
por: Oertel, Frederike Cosima, et al.
Publicado: (2023)

Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre
por: Paterson, Ross W, et al.
Publicado: (2013)

Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias
por: King, Eleanor, et al.
Publicado: (2018)

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
por: Stellmann, Jan-Patrick, et al.
Publicado: (2017)

Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders
por: Lu, Angelo, et al.
Publicado: (2022)

Autologous haematopoietic stem cell transplantation for neurological diseases
por: Burman, Joachim, et al.
Publicado: (2018)

CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications
por: Kaneko, Kimihiko, et al.
Publicado: (2018)

Peripheral immunophenotype in dementia with Lewy bodies and Alzheimer’s disease: an observational clinical study
por: Amin, Jay, et al.
Publicado: (2020)

Neuroinflammation predicts disease progression in progressive supranuclear palsy
por: Malpetti, Maura, et al.
Publicado: (2021)

Cross-sectional and longitudinal measures of chitinase proteins in amyotrophic lateral sclerosis and expression of CHI3L1 in activated astrocytes
por: Vu, Lucas, et al.
Publicado: (2020)

TNF-α inhibitors used as steroid-sparing maintenance monotherapy in parenchymal CNS sarcoidosis
por: Hilezian, Frédéric, et al.
Publicado: (2021)

In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer’s disease
por: Low, Audrey, et al.
Publicado: (2021)

Neuromyelitis optica spectrum disorder: pregnancy-related attack and predictive risk factors
por: Wang, Liang, et al.
Publicado: (2021)

Association of obesity with disease outcome in multiple sclerosis
por: Lutfullin, Isabel, et al.
Publicado: (2023)

Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis
por: Leppert, David, et al.
Publicado: (2023)

Episodic ataxia in CASPR2 autoimmunity
por: López Chiriboga, A. Sebastian, et al.
Publicado: (2018)

A Chinese female Morvan patient with LGI1 and CASPR2 antibodies: a case report
por: Zhang, Li, et al.
Publicado: (2016)

Isaacs syndrome with LGI1 and CASPR2 antibodies after HPV vaccination: A case report
por: Yang, Bufan, et al.
Publicado: (2023)

Pediatric LGI1 and CASPR2 autoimmunity associated with COVID 19: Morvan syndrome
por: Kilic, Mehmet Akif, et al.
Publicado: (2021)

Treating seizures and preventing amnesia in LGI1-antibody encephalitis: A new MRI signature?
por: Varley, James A., et al.
Publicado: (2015)

LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis
por: Jang, Yoonhyuk, et al.
Publicado: (2018)

LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures
por: Aurangzeb, Sidra, et al.
Publicado: (2017)

Anti‐LGI1, anti‐GABABR, and Anti‐CASPR2 encephalitides in Asia: A systematic review
por: Ghimire, Prinska, et al.
Publicado: (2020)

Morvan Syndrome Converted from Isaacs' Syndrome after Thymectomy with Positivity for Both Anti-LGI1 and Anti-CASPR2 Antibodies
por: Suzuki, Daisuke, et al.
Publicado: (2021)

Human Leukocyte Antigen Association Study Reveals DRB1*04:02 Effects Additional to DRB1*07:01 in Anti-LGI1 Encephalitis
por: Peris Sempere, Vicente, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kae6eobfrg1p6qokph66fh95gb